Ascendis Pharma A Income Statement (2012-2026) | ASND

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2012 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.00B0.00B0.09B0.01B0.01B0.02B0.02B0.04B0.05B0.05B0.26B0.10B0.04B0.06B0.27B0.11B0.18B0.25B0.38B0.29B
Cost of Revenue (Quarter)
0.00B0.00B0.00B0.00B0.01B0.00B0.01B0.01B0.02B0.01B0.01B0.01B0.01B0.02B0.04B0.03B0.03B0.02B
Gross Profit (Quarter)
0.00B0.00B0.00B0.00B0.01B0.01B0.02B0.03B0.04B0.04B0.13B0.10B0.03B0.05B0.17B0.09B0.14B0.22B0.26B0.27B
Operating items
Research & Development (Quarter)
0.10B0.07B0.08B0.09B0.10B0.10B0.11B0.11B0.11B0.12B0.10B0.08B0.09B-0.08B-0.08B-0.09B0.08B-0.08B-0.09B-0.07B
Selling, General & Administrative (Quarter)
0.04B0.05B0.06B0.05B0.06B0.06B0.06B0.07B0.08B0.07B0.07B0.07B0.08B-0.08B-0.09B-0.11B0.12B-0.13B-0.16B-0.17B
Other Operating Expenses (Quarter)
-0.26B-0.27B-0.23B0.14B0.14B
Operating Expenses (Quarter)
0.14B0.12B-0.13B0.15B0.16B0.16B-0.10B0.19B0.19B0.19B-0.06B0.15B0.17B-0.16B-0.03B-0.20B0.20B-0.21B-0.11B-0.24B
Operating Income (Quarter)
-0.14B-0.11B-0.13B-0.14B-0.15B-0.15B-0.15B-0.15B-0.15B-0.15B-0.04B-0.05B-0.14B-0.11B409.27B-0.11B-0.06B0.01B0.01B0.03B
EBIT (Quarter)
-0.14B-0.11B-0.13B-0.14B-0.15B-0.15B-0.15B-0.15B-0.15B-0.15B-0.04B-0.05B-0.14B-0.11B409.27B-0.11B-0.06B0.01B0.01B0.03B
Non-operating items
Interest & Investment Income (Quarter)
0.03B0.05B0.01B0.09B0.07B0.05B0.09B0.08B0.08B0.00B0.05B0.03B0.03B0.09B0.11B0.01B
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)
0.02B0.03B0.04B0.09B0.21B
Net income details
EBT (Quarter)
-0.16B-0.09B-0.12B-0.14B-0.09B-0.17B-0.21B-0.12B-0.13B-0.18B-0.09B-0.14B-0.12B-0.11B-0.04B-0.10B-0.04B-0.07B-0.03B-0.06B
Tax Provisions (Quarter)
-0.00B0.00B-0.00B-0.00B0.00B0.00B-0.01B0.00B0.00B-0.00B-0.01B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.79B
Profit After Tax (Quarter)
0.16B-0.09B-0.76B0.14B-0.09B-0.17B-0.21B-0.12B-0.13B-0.18B-0.09B0.14B0.12B-0.11B-0.04B0.10B-0.04B-0.07B-0.04B0.74B
Equity Income (Quarter)
-0.01B-0.00B-0.01B-0.01B-0.00B-0.00B-0.01B0.00B-0.01B-0.01B-0.00B-0.01B-0.01B-0.00B-0.00B-0.03B-0.00B-0.01B0.00B0.01B
Income from Continuing Operations (Quarter)
-0.16B-0.09B-0.12B-0.14B-0.09B-0.17B-0.20B-0.12B-0.13B-0.18B-0.08B-0.14B-0.12B-0.11B-0.04B-0.10B-0.04B-0.06B-0.02B0.74B
Consolidated Net Income (Quarter)
-0.16B-0.09B-0.12B-0.14B-0.09B-0.17B-0.20B-0.12B-0.13B-0.18B-0.08B-0.14B-0.12B-0.11B-0.04B-0.10B-0.04B-0.06B-0.02B0.74B
Income towards Parent Company (Quarter)
-0.16B-0.09B-0.12B0.14B-0.09B0.17B-0.21B0.12B-0.13B-0.18B-0.10B0.14B-0.12B0.11B-0.04B0.10B0.05B-0.07B-0.04B0.74B
Net Income towards Common Stockholders (Quarter)
-0.16B-0.09B-0.12B0.14B-0.09B0.17B-0.21B0.12B-0.13B-0.18B-0.10B0.14B-0.12B0.11B-0.04B0.10B0.05B-0.07B-0.04B0.74B
Additional items
EPS (Basic) (Quarter)
-36.71-15.66-1.9456.79-22.3025.55-3.7056.41-29.58-23.11-1.5756.97-25.9816.73-4.7259.9418.13-7.55-4.0962.00
EPS (Weighted Average and Diluted) (Quarter)
-14.97-22.3025.55-30.2256.41-29.58-23.11-13.5556.97-25.9816.73-5.8959.9418.13-19.43-9.0664.86
Shares Outstanding (Weighted Average) (Quarter)
0.00B0.01B0.06B0.00B0.00B0.01B0.06B0.00B0.00B0.01B0.06B0.00B0.00B0.01B0.01B0.00B0.00B0.01B0.01B0.01B
Shares Outstanding (Diluted Average) (Quarter)
0.01B0.00B0.01B0.01B0.00B0.00B0.01B0.01B0.00B0.00B0.01B0.01B0.00B0.00B0.00B0.00B0.01B
EBITDA (Quarter)
-0.16B-0.09B-0.13B-0.14B-0.09B-0.17B-0.15B-0.12B-0.13B-0.18B-0.04B-0.14B-0.12B-0.11B409.27B-0.10B-0.05B-0.07B0.01B0.74B
Interest Expenses (Quarter)
0.01B0.00B-0.00B0.01B0.01B0.04B-0.00B0.01B0.01B0.03B0.07B0.08B0.02B-0.03B-0.00B-0.05B0.04B-0.08B-0.07B0.08B
Tax Rate (Quarter)
0.05%-0.01%0.11%0.19%-0.06%-0.10%2.65%-1.18%-0.35%0.40%7.14%-1.95%0.21%1.04%2.90%1.13%10.99%6.30%25.68%1,406.31%